Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)

Huang CF, Tseng KC, Cheng PN, Hung CH, Lo CC, Peng CY, et al. Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR). Clin Gastroenterol Hepatol [Internet]. 2022;20(5):1151-1162. https://doi.org/10.1016/j.cgh.2021.07.037

Publication Type:

Journal Article

Authors:

Huang, CF; Tseng, KC; Cheng, PN; Hung, CH; Lo, CC; Peng, CY; Bair, MJ; Yeh, ML; Chen, CH; Lee, PL; Lin, CY; Kuo, HT; Chen, CT; Yang, CC; Huang, JF; Tai, CM; Hu, JT; Lin, CL; Su, WW

Source:

Clin Gastroenterol Hepatol, Volume 20, Issue 5, p.1151-1162 (2022)

URL:

https://doi.org/10.1016/j.cgh.2021.07.037

Keywords:

CKD, DAA, eGFR, Real World, sofosbuvir

Cited On:

External Third-party Web Link:

https://pubmed.ncbi.nlm.nih.gov/34333150/

Export Citation:
RIS Format
Top